Authors:
GREILICH PE
CARR ME
COOLEY MV
HARRIS DN
CARR SL
WHITTEN CW
Citation: Pe. Greilich et al., DOSE-DEPENDENT EFFECTS OF C7E3 FAB ON MODIFIED THROMBOELASTOGRAPHY INHEALTHY-VOLUNTEERS, Anesthesia and analgesia, 86(2S), 1998, pp. 64-64
Citation: Me. Carr et al., DIFFERENTIAL-EFFECTS OF THROMBOPOIETIN AND STEM-CELL FACTOR ON PLATELET CONTRACTILE-FORCE, Blood, 90(10), 1997, pp. 3002-3002
Citation: Me. Carr et al., COMPARISON OF THROMBIN-INDUCED AND BATROXOBIN-INDUCED CLOTS REVEALS REDUCED PLATELET FORCE IN CLOTTING FACTOR DEFICIENT PATIENTS, Blood, 90(10), 1997, pp. 3122-3122
Citation: Me. Carr et al., EFFECT OF FIBRINOGEN FRAGMENT-X, FRAGMENT-Y AND FRAGMENT-D ON PLASMA CLOT ELASTIC-MODULUS AND PLATELET CONTRACTILE-FORCE, Blood, 90(10), 1997, pp. 3123-3123
Authors:
CARR ME
CARR SL
MONGEMEBERG P
WILLIAMS TY
NESTLER J
Citation: Me. Carr et al., EFFECTS OF DEHYDROEPIANDROSTERONE (DHEA) ON PLATELET-FUNCTION, FIBRINOLYSIS AND CLOT STRUCTURE, Blood, 90(10), 1997, pp. 3124-3124
Authors:
CARR ME
HINES S
CARR SL
TODD WM
TAYLOR TL
MOHANTY L
Citation: Me. Carr et al., STORAGE POOL DISEASE IN CHRONIC LYMPHOCYTIC-LEUKEMIA - ABNORMAL AGGREGATION AND SECRETION WITHOUT BLEEDING, The American journal of the medical sciences, 313(3), 1997, pp. 176-181
Citation: Ka. Mccardell et al., APROTININ AUGMENTS PROTAMINE SULFATE REVERSAL OF HEPARIN ANTIPLATELETEFFECTS, Journal of investigative medicine, 44(3), 1996, pp. 212-212
Citation: Ka. Mccardell et al., APROTININ CAN REVERSE HEPARIN MEDIATED SUPPRESSION OF PLATELET FORCE DEVELOPMENT, Journal of investigative medicine, 44(3), 1996, pp. 287-287
Citation: Me. Carr et al., EFFECTS OF POLOXAMER-407 ON THE ASSEMBLY, STRUCTURE AND DISSOLUTION OF FIBRIN CLOTS, Blood coagulation & fibrinolysis, 7(2), 1996, pp. 109-113
Citation: Me. Carr et al., HEPARIN ABLATES FORCE DEVELOPMENT DURING PLATELET-MEDIATED CLOT RETRACTION, Thrombosis and haemostasis, 75(4), 1996, pp. 674-678
Citation: Me. Carr et al., ABNORMAL FIBRIN STRUCTURE AND INHIBITION OF FIBRINOLYSIS IN PATIENTS WITH MULTIPLE-MYELOMA, The Journal of laboratory and clinical medicine, 128(1), 1996, pp. 83-88
Citation: Me. Carr et al., COMPARISON OF HEMODYNE(R) HEMOSTASIS ANALYZER AND THROMBOELASTOGRAN(R) ABILITIES TO DETECT EFFECTS OF ALTERED FIBRIN AND PLATELET CONCENTRATIONS, Blood, 88(10), 1996, pp. 2961-2961
Citation: Me. Carr et al., USE OF TPA-INDUCED CLOT LYSIS TIME (TCLOT) TO DIAGNOSE ABNORMAL CLOT STRUCTURE AND FIBRINOLYSIS IN A PATIENT WITH SPONTANEOUS BLEEDING INTOHIS LEG, Angiology, 47(10), 1996, pp. 941-949
Citation: Me. Carr et al., A SENSITIVE PLATELET ACTIVATION-BASED FUNCTIONAL ASSAY FOR THE ANTILEUKEMIC AGENT BRYOSTATIN-1, Anti-cancer drugs, 6(3), 1995, pp. 384-391
Citation: Me. Carr et Sl. Carr, FIBRIN STRUCTURE AND CONCENTRATION ALTER CLOT ELASTIC-MODULUS BUT DO NOT ALTER PLATELET-MEDIATED FORCE DEVELOPMENT, Blood coagulation & fibrinolysis, 6(1), 1995, pp. 79-86
Citation: Me. Carr et al., GLYCOPROTEIN IIB IIIA BLOCKADE INHIBITS PLATELET-MEDIATED FORCE DEVELOPMENT AND REDUCES GEL ELASTIC-MODULUS/, Thrombosis and haemostasis, 73(3), 1995, pp. 499-505
Citation: Me. Carr et al., EFFECTS OF IONIC AND NONIONIC CONTRAST-MEDIA ON CLOT STRUCTURE, PLATELET-FUNCTION AND THROMBOLYSIS MEDIATED BY TISSUE-PLASMINOGEN ACTIVATORIN PLASMA CLOTS, Haemostasis, 25(4), 1995, pp. 172-181
Citation: Me. Carr et al., IS PLATELET DYSFUNCTION CLINICALLY SIGNIFICANT IN STEM-CELL DISORDERS- ABNORMAL PLATELET-AGGREGATION WITH NORMAL FORCE DEVELOPMENT IN ESSENTIAL THROMBOCYTOSIS, Blood, 86(10), 1995, pp. 3155-3155
Authors:
CARR ME
ANGCHAISUKSIRI P
CARR SL
BARNES J
Citation: Me. Carr et al., EFFECT OF ANTITHROMBIN-III CONCENTRATE, ALONE OR WITH HEPARIN, ON CLOT STRUCTURE AND PLATELET-FUNCTION, Blood, 86(10), 1995, pp. 3452-3452
Citation: Me. Carr et al., EFFECT OF ADENOSINE A(2)-RECEPTOR AGONIST (NECA) ON PLATELET-FUNCTION, FIBRIN STRUCTURE AND PLASMA CLOT DISSOLUTION, Blood, 86(10), 1995, pp. 3567-3567